PD-L2 was also significantly upregulated on the surface of tumour-infiltrating CD4+ T cells and CD8+ T cells compared with the levels in circulation in the treatment-naïve setting (p = 0.001 and p = 0.001) (Fig. 1K.). This evidence concerns the gene PDCD1LG2 and neoplasm.